Comparative efficacy, recovery, and pigmentary safety of radiofrequency microneedling and fractional carbon dioxide laser for facial atrophic acne scars: a prospective randomized split-face trial [0.03%]
射频微针与点阵CO2激光治疗面部萎缩性痤疮疤痕有效性和色素安全性的比较：一项前瞻性随机半面试验
Wei Li,Chunjiao Zheng,Xiaohai Yuan et al.
Wei Li et al.
Objective: To compare efficacy, recovery, pigmentary safety, and patient-reported outcomes of radiofrequency microneedling (RFMN) and fractional carbon dioxide laser (FCO2) for facial atrophic acne scars. ...
Randomized Controlled Trial
The Journal of dermatological treatment. 2026 Dec;37(1):2687842. DOI:10.1080/09546634.2026.2687842 2026
Roflumilast foam versus vehicle foam for seborrheic dermatitis (STRATUM clinical study): a plain language summary [0.03%]
布地奈德泡沫与空白对照泡沫治疗脂溢性皮炎（STRATUM临床研究）：简易总结报告
Andrew Blauvelt,Zoe D Draelos,Linda Stein Gold et al.
Andrew Blauvelt et al.
Long-term treatment of atopic dermatitis with roflumilast cream 0.15% in patients aged 6 years or older (INTEGUMENT-OLE clinical study): a plain language summary [0.03%]
关于克罗米洛酯乳膏治疗6岁及以上年龄的特应性皮炎患者的长期疗效（INTEGUMENT-OLE临床研究）的白话文摘要
Eric Simpson,Lawrence F Eichenfield,Kim A Papp et al.
Eric Simpson et al.
Exploring the mechanism of differential responses to combination therapy in melasma: pigmentary versus mixed pigmentary-vascular types-a clinical study based on interaction analysis [0.03%]
白癜霜联合治疗褐斑色素型与色素血管混合型差异反应机制的临床研究——基于互作分析
Xiaoyan Li,Lei Nie,Wei Guo et al.
Xiaoyan Li et al.
Background: Melasma shows clinical heterogeneity, but the role of vascular components in treatment resistance remains unclear. Methods: ...
The diameter of malformation capillaries does not influence the efficacy of photodynamic therapy for facial port-wine stains: a pilot study [0.03%]
畸形血管直径不会影响面部葡萄酒色斑光动力治疗的效果：一项前瞻性研究
Limin Hao,Wen Ju,Yuanbo Huang
Limin Hao
Background: Photodynamic therapy (PDT) is an effective treatment for port-wine stains (PWS). However, the relationship between the diameter of malformed capillaries and the efficacy of PDT in PWS has been rarely studied. ...
Benefit-risk profile comparison between dupilumab and upadacitinib: a structured benefit-risk assessment of the Heads Up trial [0.03%]
Dupixent（杜匹鲁单抗）与Upadacitinib（乌帕替尼）的风险效益对比：Heads Up试验的结构化风险效益评估
Andrew Blauvelt,Eric L Simpson,Kilian Eyerich et al.
Andrew Blauvelt et al.
Objectives: Structured benefit-risk assessments evaluate multiple patient-relevant endpoints simultaneously, weighing therapeutic benefits against risks, enabling healthcare professionals and patients to select the most s...
Unveiling the IL-17 axis: an immunometabolic bridge between psoriasis and metabolic syndrome [0.03%]
揭示IL-17轴：银屑病和代谢综合征之间的一种免疫代谢联系
Paolo Gisondi,Zeno Fratton,Ralph Vighi da Rosa et al.
Paolo Gisondi et al.
Aim of the review: Psoriasis is increasingly recognized as a systemic inflammatory disease frequently associated with a cluster of cardiometabolic comorbidities, including obesity, type 2 diabetes, and cardiovascular dise...
Effects of extended-release topical polyhexanide in a Staphylococcus aureus-induced murine dermatitis model characterized by IL-36 expression [0.03%]
聚己六酸酯缓释外用制剂对金黄色葡萄球菌诱导的小鼠皮炎模型中IL-36表达的影响
Bradley Burnam,Stephen Bresnick
Bradley Burnam
Objectives: Atopic dermatitis is a chronic inflammatory skin disorder characterized by epidermal barrier dysfunction, microbial dysbiosis, and dysregulated immune signaling. Staphylococcus aureus colonization is associate...
Tiago Almeida Santos Costa,Isabella Bonilha,Sheila Tatsumi Kimura Medorima et al.
Tiago Almeida Santos Costa et al.
Introduction: Psoriasis is a chronic immune-mediated inflammatory dermatosis associated with systemic comorbidities, including metabolic disorders, atherosclerosis, and increased cardiovascular mortality. ...